Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP19A1 | P11511 | 2/20 | 0.45 |
| ▸ | LDHA | P00338 | 1/20 | 0.44 |
| ▸ | MRGPRX4 | Q96LA9 | 2/20 | 0.40 |
| ▸ | CETP | P11597 | 1/20 | 0.35 |
| ▸ | HTR1A | P08908 | 1/20 | 0.34 |
| ▸ | DRD2 | P14416 | 2/20 | 0.34 |
| ▸ | DRD3 | P35462 | 2/20 | 0.34 |
| ▸ | ELANE | P08246 | 2/20 | 0.32 |
| ▸ | FADS1 | O60427 | 2/20 | 0.32 |
| ▸ | TRPM8 | Q7Z2W7 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | GRM5 | P41594 | 1/20 | 0.31 |
| ▸ | ENPP1 | P22413 | 1/20 | 0.31 |
| ▸ | TEAD1 | P28347 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31346110 | 1.00 | CYP19A1 (0.45) | CYP19A1LDHAMRGPRX4CETPHTR1A | |
| SCHEMBL31346169 | 0.84 | CYP19A1 (0.49) | CYP19A1LDHAMRGPRX4DRD2DRD3 | |
| SCHEMBL31345985 | 0.82 | TEAD1 (0.37) | MRGPRX4HTR1ADRD3CYP3A4TEAD1 | |
| SCHEMBL31345995 | 0.80 | CYP19A1 (0.45) | CYP19A1LDHAMRGPRX4CETPHTR1A | |
| SCHEMBL31346117 | 0.80 | CYP19A1 (0.45) | CYP19A1LDHAMRGPRX4CETPHTR1A | |
| SCHEMBL31345956 | 0.79 | LMNA (0.34) | MRGPRX4HTR1ATEAD1 | |
| SCHEMBL31346090 | 0.79 | ALDH1A1 (0.43) | MRGPRX4TRPM8 | |
| SCHEMBL31345967 | 0.78 | CA2 (0.37) | — | |
| SCHEMBL31346003 | 0.78 | CTSS (0.42) | MRGPRX4 | |
| SCHEMBL31346021 | 0.78 | CYP19A1 (0.42) | CYP19A1LDHAMRGPRX4CETPHTR1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4712967-A2 | G-PROTEIN COUPLED RECEPTOR ANTAGONIST | Enveda Therapeutics, Inc. (US) | 2026-03-25 | — | — | EP | disclosed |
| WO-2024239000-A2 | G-PROTEIN COUPLED RECEPTOR ANTAGONIST | ENVEDA THERAPEUTICS, INC. (US) | 2024-11-21 | — | — | WO | disclosed |